|
1
|
Nakanishi T, Chumsri S, Khakpour N, Brodie
AH, Leyland-Jones B, Hamburger AW, Ross DD and Burger AM:
Side-population cells in luminal-type breast cancer have
tumour-initiating cell properties, and are regulated by HER2
expression and signalling. Br J Cancer. 102:815–826. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hu C, Li H, Li J, Zhu Z, Yin S, Hao X, Yao
M, Zheng S and Gu J: Analysis of ABCG2 expression and side
population identifies intrinsic drug efflux in the HCC cell line
MHCC-97L and its modulation by Akt signaling. Carcinogenesis.
29:2289–2297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hu L, McArthur C and Jaffe RB: Ovarian
cancer stem-like side-population cells are tumourigenic and
chemoresistant. Br J Cancer. 102:1276–1283. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salcido CD, Larochelle A, Taylor BJ,
Dunbar CE and Varticovski L: Molecular characterisation of side
population cells with cancer stem cell-like characteristics in
small-cell lung cancer. Br J Cancer. 102:1636–1644. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu T, Xu F, Du X, Lai D, Liu T, Zhao Y,
Huang Q, Jiang L, Huang W, Cheng W, et al: Establishment and
characterization of multi-drug resistant, prostate
carcinoma-initiating stem-like cells from human prostate cancer
cell lines 22RV1. Mol Cell Biochem. 340:265–273. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Natarajan K, Xie Y, Baer MR and Ross DD:
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer
drug resistance. Biochem Pharmacol. 83:1084–1103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Diah SK, Smitherman PK, Aldridge J, Volk
EL, Schneider E, Townsend AJ and Morrow CS: Resistance to
mitoxantrone in multidrug-resistant MCF7 breast cancer cells:
Evaluation of mitoxantrone transport and the role of multidrug
resistance protein family proteins. Cancer Res. 61:5461–5467.
2001.PubMed/NCBI
|
|
8
|
Jendzelovský R, Mikes J, Koval' J, Soucek
K, Procházková J, Kello M, Sacková V, Hofmanová J, Kozubík A and
Fedorocko P: Drug efflux transporters, MRP1 and BCRP, affect the
outcome of hypericin-mediated photodynamic therapy in HT-29
adenocarcinoma cells. Photochem Photobiol Sci. 8:1716–1723. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jendželovský R, Koval J, Mikeš J, Papčová
Z, Plšíková J and Fedoročko P: Inhibition of GSK-3β reverses the
pro-apoptotic effect of proadifen (SKF-525A) in HT-29 colon
adenocarcinoma cells. Toxicol In Vitro. 26:775–782. 2012.
View Article : Google Scholar
|
|
10
|
Ozvegy-Laczka C, Hegedus T, Várady G,
Ujhelly O, Schuetz JD, Váradi A, Kéri G, Orfi L, Német K and
Sarkadi B: High-affinity interaction of tyrosine kinase inhibitors
with the ABCG2 multidrug transporter. Mol Pharmacol. 65:1485–1495.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kleban J, Mikes J, Szilárdiová B, Koval J,
Sacková V, Solár P, Horváth V, Hofmanová J, Kozubík A and Fedorocko
P: Modulation of hypericin photodynamic therapy by pretreatment
with 12 various inhibitors of arachidonic acid metabolism in colon
adenocarcinoma HT-29 cells. Photochem Photobiol. 83:1174–1185.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chou TC and Talalay P: Quantitative
analysis of dose-effect relationships: The combined effects of
multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jendželovská Z, Jendželovský R, Hiľovská
L, Kovaľ J, Mikeš J and Fedoročko P: Single pre-treatment with
hypericin, a St. John's wort secondary metabolite, attenuates
cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis
and HL-60 cells. Toxicol In Vitro. 28:1259–1273. 2014. View Article : Google Scholar
|
|
14
|
Kretschy N, Teichmann M, Kopf S, Atanasov
AG, Saiko P, Vonach C, Viola K, Giessrigl B, Huttary N, Raab I, et
al: In vitro inhibition of breast cancer spheroid-induced
lymphendothelial defects resembling intravasation into the
lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and
proadifen. Br J Cancer. 108:570–578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spitzmaul G, Gumilar F, Dilger JP and
Bouzat C: The local anaesthetics proadifen and adiphenine inhibit
nicotinic receptors by different molecular mechanisms. Br J
Pharmacol. 157:804–817. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hoferová Z, Soucek K, Hofmanová J, Hofer
M, Chramostová K, Fedorocko P and Kozubik A: In vitro proliferation
of fibrosarcoma cells depends on intact functions of lipoxygenases
and cytochrome P-450-monooxygenase. Cancer Invest. 22:234–247.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hofmanová J, Soucek K, Dusek L, Netíková J
and Kozubík A: Inhibition of the cytochrome P-450 modulates
all-trans-retinoic acid-induced differentiation and apoptosis of
HL-60 cells. Cancer Detect Prev. 24:325–342. 2000.PubMed/NCBI
|
|
18
|
Huang YC and Han YS: Determining
anti-betanodavirus compounds through a GF-1 cell-based screening
platform. Antiviral Res. 105:47–53. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fernández G, Villarruel MC, Bernacchi A,
de Castro CR and Castro JA: Effects of repeated administration of
rat 2-diethyl-aminoethyl-2-2-diphenylvalerate-HCI (SKF 525 A) on
liver. Toxicology. 20:185–193. 1981. View Article : Google Scholar
|
|
20
|
Elahian F, Kalalinia F and Behravan J:
Evaluation of indo-methacin and dexamethasone effects on
BCRP-mediated drug resistance in MCF-7 parental and resistant cell
lines. Drug Chem Toxicol. 33:113–119. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chu TS, Chen JS, Lopez JP, Pardo FS,
Aguilera J and Ongkeko WM: Imatinib-mediated inactivation of Akt
regulates ABCG2 function in head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg. 134:979–984. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakanishi T, Shiozawa K, Hassel BA and
Ross DD: Complex interaction of BCRP/ABCG2 and imatinib in
BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is
attenuated by imatinib-induced reduction of BCRP expression. Blood.
108:678–684. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rosenfeldt MT, Bell LA, Long JS, O'Prey J,
Nixon C, Roberts F, Dufès C and Ryan KM: E2F1 drives
chemotherapeutic drug resistance via ABCG2. Oncogene. 33:4164–4172.
2014. View Article : Google Scholar
|
|
24
|
Breitenbuecher F, Markova B, Kasper S,
Carius B, Stauder T, Böhmer FD, Masson K, Rönnstrand L, Huber C,
Kindler T, et al: A novel molecular mechanism of primary resistance
to FLT3-kinase inhibitors in AML. Blood. 113:4063–4073. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Glaser SP, Lee EF, Trounson E, Bouillet P,
Wei A, Fairlie WD, Izon DJ, Zuber J, Rappaport AR, Herold MJ, et
al: Anti-apoptotic Mcl-1 is essential for the development and
sustained growth of acute myeloid leukemia. Genes Dev. 26:120–125.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hermanson DL, Das SG, Li Y and Xing C:
Overexpression of Mcl-1 confers multidrug resistance, whereas
topoisomerase IIβ downregulation introduces mitoxantrone-specific
drug resistance in acute myeloid leukemia. Mol Pharmacol.
84:236–243. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fuessel S, Herrmann J, Ning S, Kotzsch M,
Kraemer K, Schmidt U, Hakenberg OW, Wirth MP and Meye A:
Chemosensitization of bladder cancer cells by survivin-directed
antisense oligodeoxy-nucleotides and siRNA. Cancer Lett.
232:243–254. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dong H, Liu G, Jiang B, Guo J, Tao G, Yiu
W, Zhou J and Li G: The effects of aspirin plus cisplatin on
SGC7901/CDDP cells in vitro. Biomed Rep. 2:344–348. 2014.PubMed/NCBI
|
|
29
|
Li G, Zhang S, Fang H, Yan B, Zhao Y, Feng
L, Ma X and Ye X: Aspirin overcomes Navitoclax-resistance in
hepatocellular carcinoma cells through suppression of Mcl-1.
Biochem Biophys Res Commun. 434:809–814. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bank A, Yu J and Zhang L: NSAIDs
downregulate Bcl-X(L) and dissociate BAX and Bcl-X(L) to induce
apoptosis in colon cancer cells. Nutr Cancer. 60(Suppl 1):
S98–S103. 2008. View Article : Google Scholar
|
|
31
|
Zhang DQ, Guo Q, Zhu JH and Chen WC:
Increase of cyclo-oxygenase-2 inhibition with celecoxib combined
with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a
subcutaneous implantation tumor model of human colon cancer. World
J Surg Oncol. 11:162013. View Article : Google Scholar
|
|
32
|
Paull TT, Rogakou EP, Yamazaki V,
Kirchgessner CU, Gellert M and Bonner WM: A critical role for
histone H2AX in recruitment of repair factors to nuclear foci after
DNA damage. Curr Biol. 10:886–895. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kalra RS and Bapat SA: Enhanced levels of
double-strand DNA break repair proteins protect ovarian cancer
cells against genotoxic stress-induced apoptosis. J Ovarian Res.
6:662013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Koike A, Nishikawa H, Wu W, Okada Y,
Venkitaraman AR and Ohta T: Recruitment of phosphorylated NPM1 to
sites of DNA damage through RNF8-dependent ubiquitin conjugates.
Cancer Res. 70:6746–6756. 2010. View Article : Google Scholar : PubMed/NCBI
|
